MaxCyte, Inc. Common Stock (MXCT) is a publicly traded Healthcare sector company. As of May 21, 2026, MXCT trades at $1.07 with a market cap of $113.55M and a P/E ratio of -2.49. MXCT moved +1.44% today. Year to date, MXCT is -30.97%; over the trailing twelve months it is -50.92%. Its 52-week range spans $0.64 to $5.20. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces MXCT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for MXCT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $1.07 |
| Market Cap | $113.55M |
| P/E Ratio | -2.49 |
| EPS | $-0.42 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.20 |
| 52-Week Low | $0.64 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $33.03M |
| Net Income | $-44.63M |
| Gross Margin | 81.16% |
5 analysts cover MXCT: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.